Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caspofungin versus liposomal amphotericin B for empirical treatment of persistent fever in neutropenic children receiving chemotherapy
2006-001549-32Phase 4Completed
- Sponsor
- Italian Association of Pediatric Hematology and Oncology
- Start
- Jul 2007
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Antimicrobial Peptides → Native Peptides → Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial in febrile neutropenia (FN) and invasive mycoses comparing Caspofungin with Liposomal amphotericin B (2 arms). Primary endpoint: Persistence of fever. Started Jul 2007; status: completed.
02
Drugs
caspofunginliposomal amphotericin b
03
Conditions
febrile neutropenia (FN)invasive mycoses
Beyond the preview
Go deeper on 2006-001549-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001549-32.